Qiagen NV | QIA - 应收帐款人

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.31B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	应收帐款人	更改		日
Akebia Therapeutics	USD 47.03M		19.19M	2025-12
Alaunos Therapeutics	USD 2K		0	2025-06
argenx SE	USD 2.01B		352.94M	2026-06
Avita Medical	AUD 9.11M		2.26M	2025-12
Dianthus Therapeutics	USD 1.23M		1.18M	2026-03
Ionis Pharmaceuticals	USD 58.84M		15.16M	2026-06
IQVIA Holdings	USD 3.39B		12M	2026-06
Moderna	USD 17M		54M	2026-06
Organon & Co	USD 1.49B		108M	2026-06
Qiagen NV	USD 398.35M		1.73M	2026-06
Revvity	USD 709.18M		17.79M	2026-06
Tectonic Therapeutic	USD 0		270K	2023-12
Viatris	USD 3.13B		49.9M	2026-06
Xeris Pharmaceuticals	USD 56.29M		5.24M	2026-03